Australia's Translational Research Institute (TRI) brings together the intellectual capacity and medical expertise of two universities and two hospitals. It is co-located with a biopharmaceutical manufacturer on the grounds of the PA Hospital. TRI works to translate scientific innovations into improvements in healthcare.
The TRI translational research model sees a distinctive role played by each member of a multi-disciplinary team that collectively agree on the clinical question, the goal and the required outcomes. The model addresses emerging research needs through the internationally accepted translational pathway from T1 to T5.